India, Dec. 3 -- Tata Motors has bagged a huge order of over 2,300 buses from various State Transport Undertakings, namely Rajasthan (RSRTC), Karnataka (KSRTC/ BMTC/ NWKRTC), Uttar Pradesh (UPSRTC), Tamil Nadu (IRT), and Andhra Pradesh (APSRTC). Tata Motors is working towards completing this order by February 2020.

Biocon and Mylan NV have launched Ogivri (trastuzumab-dkst), a biosimilar to Herceptin (trastuzumab). Ogivri is available in a 420 mg multi-dose vial and a 150 mg single-dose vial in order to provide patient dosing and treatment flexibility.

Gufic Biosciences has received Patent Certificate from the Patent Office, The Government of India, granting patent to the Company for Parenteral Formulations of Levosimendan.

Thomas Cook h...